Write For Us

Covid-19 News | 70-80% Reduction In Covaxin Trial Participation: AIIMS

Sponsored Post Vitamin D2 Canada Persia
123 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Covid-19 News: The results of the first phase trial of Covid vaccine candidate Covaxin, developed by Bharat Biotech, show that the vaccine induced an immune response and did not lead to any serious side-effects, this according to a pre-print study published by Bharat Biotech. This has not been peer-reviewed, which means it hasn't been reviewed by a third party. An AIIMS doctor said that for the third phase of trial of the Bharat Biotech vaccine, there's a 70-80 per cent reduction in those volunteering for the test.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
Category
Asia
Tags
NDTV 24x7, Covid vaccine candidate, ICMR
Sign in or sign up to post comments.
Be the first to comment